Tenaya Therapeutics

TNYANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$72.641 M

$0.32 -13.84%

Close of 6 Nov 2026

As of 6 Nov 2026, Tenaya Therapeutics (TNYA) has a market capitalization of $72.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$90.6M

Loss-making

Shares outstanding

227,928,240

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#116Atara BiotherapeuticsATRA$80.7M
#117OKYO PharmaOKYO$73.5M
#118Tenaya TherapeuticsTNYA$72.6M
#119Champions OncologyCSBR$66.7M
#120Cognition TherapeuticsCGTX$60.2M

What if Tenaya Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$123,884.93

Per share 388,720× higher

Bitcoin $1.53T

$6,703.20

Per share 21,033× higher

Apple $5.02T

$22,005.97

Per share 69,049× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Tenaya Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.